◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

MatsukiyoCocokara & Co. (3088) EPS 2022–2026

Name: MatsukiyoCocokara & Co. (3088) eps history 2022-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-10

MatsukiyoCocokara & Co. annual earnings per share (EPS) for fiscal 2026 was JPY 139.89, an increase of 4.5% from JPY 133.81 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

3088 Annual EPS

EPS (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Diluted EPS	JPY 140M	JPY 134M	JPY 125M	JPY 96M	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3088 Quarterly EPS

EPS (quarterly)	2025-06-30
Diluted EPS	JPY 32M

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EPS at Comparable Companies

3391 EPS — Tsuruha Holdings Inc.
7649 EPS — Sugi Holdings Co.,Ltd.
3349 EPS — COSMOS Pharmaceutical Corporation
9989 EPS — Sundrug Co.,Ltd.
3549 EPS — Kusuri No Aoki Holdings Co., Ltd.
3148 EPS — Create SD Holdings Co., Ltd.

More 3088 metrics: Revenue · Gross Profit · Operating Income · Net Income · Free Cash Flow

All 3088 financial statements → Interactive 3088 charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.